ALZAMEND NEURO, INC. (ALZN) earnings per share
Annual history
Fiscal years 2022 – 2025
USD / SHARE 4 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-04-30 | -$11.32 | 2025-07-22 |
| FY 2024 | 2024-04-30 | -$132.33 | 2024-07-30 |
| FY 2023 | 2023-04-30 | -$206.01 | 2023-07-27 |
| FY 2022 | 2022-04-30 | -$189.00 | 2022-07-19 |
Quarterly history
Fiscal years 2022 – 2026
USD / SHARE 19 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q3 2026 | 2026-01-31 | -$0.58 | 2026-03-11 |
| Q2 2026 | 2025-10-31 | -$0.30 | 2025-12-09 |
| Q1 2026 | 2025-07-31 | -$1.28 | 2025-09-10 |
| Q4 2025 | 2025-04-30 | -$1.78 | 2025-07-22 |
| Q3 2024 | 2025-01-31 | -$1.75 | 2025-03-10 |
| Q2 2024 | 2024-10-31 | -$3.61 | 2024-12-11 |
| Q1 2024 | 2024-07-31 | -$11.42 | 2024-09-11 |
| Q4 2024 | 2024-04-30 | -$10.65 | 2024-07-30 |
| Q3 2024 | 2024-01-31 | -$33.93 | 2024-03-25 |
| Q2 2024 | 2023-10-31 | -$39.87 | 2023-12-15 |
| Q1 2024 | 2023-07-31 | -$48.42 | 2023-09-13 |
| Q4 2023 | 2023-04-30 | -$45.81 | 2023-07-27 |
| Q3 2023 | 2023-01-31 | -$74.70 | 2023-03-15 |
| Q2 2022 | 2022-10-31 | -$43.20 | 2022-12-12 |
| Q1 2022 | 2022-07-31 | -$40.50 | 2022-09-13 |
| Q4 2022 | 2022-04-30 | — | 2022-07-19 |
| Q3 2022 | 2022-01-31 | — | 2022-03-15 |
| Q2 2022 | 2021-10-31 | — | 2021-12-13 |
| Q1 2022 | 2021-07-31 | — | 2021-09-13 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (3 split s since 2023).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
ALZN CIK 0001677077 Source: EDGAR filings · all facts